We welcome Docor International joining the group of investors and the board of Directors, and are sure that they will make a great contribution to the Company."
Dr Alon Dumanis, CEO of Docor International, says: "After examining the company's capabilities and the market potential, it is our impression that Arbel's product is based on a ground-breaking technology that has already created considerable interest in the medical community. We are delighted to add Arbel Medical to Docor's portfolio, and intend to help the company meet its business goals with our experience and know-how in the field of life sciences."
About Arbel Medical
Arbel Medical, established in 2006, is active in the field of minimal-invasive treatments. The company is developing next generation medical devices for removing tumors by freezing (cryotherapy).
Among Arbel Medical's investors are Giza Venture Capital, which led the last capital raising round, the Ofer High Tech Group, the US-based Bridge Investment Fund, Docor International, TRD and Fattal.
About Docor International B.V
A leading investment group, Docor International B.V is part of the Van Leer Group Foundation. Docor invests in advanced technology-based companies with an Israeli presence, that make a significant contribution to the local economy. It focuses on companies in the life sciences, information technology and on industrial sectors with innovative technologies.
About Giza Venture Capital
Giza Venture Capital was established in 1992 and was one of the first
Israeli investors specializing in early stage and seed investment. Giza
manages around $500 million in four funds, and has invested in 87 companies
with 32 exits
|SOURCE Arbel Medical|
Copyright©2008 PR Newswire.
All rights reserved